Moderna’s stock tumbles after reported leak of data for cancer vaccine

The Quick Take
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to MarketWatch.


